CellCept, Mycophenolate

CellCept, Mycophenolate Newswire

Comprehensive Real-Time News Feed for CellCept, Mycophenolate (generic).

Results 1 - 20 of 45 in CellCept, Mycophenolate (generic)

  1. Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanerceptRead the original story

    Wednesday Dec 10 | BioMed Central

    BackgroundSeveral disorders may present with mononeuritis multiplex and the etiological diagnosis can be challenging.Case presentationWe report a 42-year old female who presented with severe lower limb neuropathic pain, asymmetric weakness and sensory impairment and was diagnosed with mononeuritis multiplex. Biopsy showed a granulomatous vasculitic process with eosinophils, scarce granulomata and axonal neuropathy and granulomatosis with poliangiitis was assumed.

    Comment?

  2. Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized, Controlled Trial.Read the original story

    Friday Dec 5 | CiteULike

    Treatment of lupus nephritis remains challenging. To assess the efficacy and safety of a multitarget therapy consisting of tacrolimus, mycophenolate mofetil, and steroid compared with intravenous cyclophosphamide and steroid as induction therapy for LN.

    Comment?

  3. Treatment of lupus nephritis: practical issues in Asian countries.Read the original story

    Friday Dec 5 | CiteULike

    Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus in Asian patients, and is an important cause of renal failure in Asian countries. Immunosuppressive treatments of LN have evolved over the past few decades and resulted in improvements in patient outcomes.

    Comment?

  4. Maintenance therapy of lupus nephritis with mycophenolate or...Read the original story

    Friday Dec 5 | CiteULike

    The objective of this study was to summarize the comparative efficacy and safety of MMF and AZA as maintenance therapy for LN. Systematic review and meta-analysis of randomized clinical trials of MMF and AZA as maintenance therapy for LN were performed based on a sensitive search.

    Comment?

  5. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic reviewRead the original story

    Thursday Dec 4 | BioMed Central

    IgA nephropathy is the most common primary glomerular disease worldwide and also the most frequent cause of kidney failure. Mycophenolate mofetil is a selective immunosuppressant widely used in many autoimmune diseases.

    Comment?

  6. Drug Combo Found to Help Lupus PatientsRead the original story w/Photo

    Nov 12, 2014 | News Max

    A combination of drugs may offer a better way to combat a serious kidney complication that commonly affects people with lupus, a new study from China suggests. In a trial of more than 300 Chinese patients with the condition, known as lupus nephritis, those who were given a trio of powerful drugs were more likely to see a complete remission.

    Comment?

  7. Triple drug combo benefits lupus nephritisRead the original story w/Photo

    Nov 11, 2014 | PhysOrg Weblog

    In a trial of 368 Chinese patients with lupus nephritis, those who were given a trio of medications were more likely to see a complete remission. The researchers, led by Zhihong Liu, M.D., of the Nanjing University School of Medicine in China, reported the findings online Nov. 11 in the Annals of Internal Medicine .

    Comment?

  8. Drug Combo Helps Lupus-Related Kidney ConditionRead the original story w/Photo

    Nov 10, 2014 | Mental Help Net

    A combination of drugs may offer a better way to combat a serious kidney complication that commonly affects people with lupus, a new study from China suggests. In a trial of more than 300 Chinese patients with the condition, known as lupus nephritis, those who were given a trio of powerful drugs were more likely to see a complete remission.

    Comment?

  9. Multidrug, multitarget regimen results in higher remission rates for lupus nephritis patientsRead the original story w/Photo

    Nov 10, 2014 | Medical News Today

    A multidrug, multitarget regimen proves superior to intravenous cyclophosphamide as induction therapy for lupus nephritis , according to a randomized, controlled trial being published in Annals of Internal Medicine . LN is the inflammation of the kidney caused by systemic lupus erythematosus.

    Comment?

  10. News from Nov. 11, 2014 Annals of Internal MedicineRead the original story w/Photo

    Nov 9, 2014 | EurekAlert!

    New guidelines from the AABB specify clinical situations in which platelet transfusion is recommended in adult patients. The guidelines are being published in Annals of Internal Medicine .

    Comment?

  11. Hypertensive Renal Injury Is Associated with Gene Variation Affecting ...Read the original story

    Nov 3, 2014 | Circulation

    The spontaneously hypertensive rat strain exists in lines that contrast strongly in susceptibility to renal injury in hypertension. These inbred lines share common ancestry and only 13% of their genomes arise from different ancestors.

    Comment?

  12. Current and emerging strategies for the prevention of graft-versus-host disease.Read the original story

    Oct 28, 2014 | CiteULike

    Graft-versus-host disease represents the most serious and challenging complication of allogeneic haematopoietic stem-cell transplantation . New insights on the role of regulatory T-cells, T cells, and antigen-presenting cells have led to an improved understanding of the pathophysiology of GVHD.

    Comment?

  13. Liver transplantation: immunosuppression and oncology.Read the original story

    Oct 26, 2014 | CiteULike

    Long-term survival of liver transplant recipients is threatened by increased rates of de-novo malignancy and recurrence of hepatocellular carcinoma , both events tightly related to immunosuppression. There is accumulating evidence linking increased exposure to immunosuppressants and carcinogenesis, particularly concerning calcineurin inhibitors , azathioprine and antilymphocyte agents.

    Comment?

  14. Aurinia To Host Lupus Opinion Leader Meeting And Webcast On October 23 In New York CityRead the original story

    Oct 21, 2014 | BioSpace

    Aurinia Pharmaceuticals Inc. today announced that it will host a Lupus Key Opinion Leader breakfast on Thursday, October 23, 2014 from 8am-9:30am Eastern Time in New York City. The meeting will feature Mary Anne Dooley, M.D. MPH, an internationally renowned expert and a pioneering leader in many national and international lupus initiatives, including the Systemic Lupus International Collaborating Clinics and the Lupus Clinical Trials Consortium.

    Comment?

  15. Blood test helps predict relapse in patients with autoimmune disease affecting the kidneysRead the original story w/Photo

    Oct 16, 2014 | Science Daily

    Among patients with an autoimmune disease called ANCA-associated vasculitis, autoantibody increases were linked with an 11-fold increased risk of relapse in patients whose kidneys were affected, a study concludes. Among patients without kidney involvement, such increases were associated only weakly with relapses.

    Comment?

  16. Blood test helps predict relapse in patients with autoimmune disease affecting the kidneysRead the original story w/Photo

    Oct 16, 2014 | PhysOrg Weblog

    In patients with an autoimmune disease that often involves the kidneys, monitoring the blood for autoantibodies may help doctors predict the chance of relapse. The findings are from a study appearing in an upcoming issue of the Journal of the American Society of Nephrology .

    Comment?

  17. Sjogren s syndrome and Neuromyelitis Optica spectrum...Read the original story

    Oct 8, 2014 | BioMed Central

    BackgroundNeuromyelitis optica is a rare relapsing auto-immune disease of the central nervous system which is sometimes found in association with other autoimmune disorders including Sjogren's syndrome. We present the case of a middle aged female with Sjogren's syndrome and Neuromyelitis optica spectrum disorders who had a rapidly declining neurological illness that responded to immunosuppressive therapy.Case presentationA 51-year-old female with Sjogren's syndrome and recent history of varicella zoster infection presented with right upper and lower extremity weakness of one week duration.

    Comment?

  18. Extracorporeal photopheresis for treatment of adults and children...Read the original story

    Oct 7, 2014 | Bone Marrow Transplantation

    Correspondence: Dr E Das-Gupta, Centre for Clinical Haematology, Nottingham University Hospitals, City Hospital Campus, Hucknall Road, Nottingham NG5 1PB, UK. E-mail: Emma.das-gupta@nhs.net Extracorporeal photopheresis has been used for over 20 years to treat acute GVHD and chronic GVHD.

    Comment?

  19. Interleukin-2-stimulated natural killer cells are less susceptible to ...Read the original story

    Sep 23, 2014 | CiteULike

    Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy. In a clinical phase I/II trial, pediatric patients with high-risk malignancies were treated with ex vivo IL-2-stimulated donor natural killer cells after transplantation with haploidentical stem cells.

    Comment?

  20. ''Feeble' Health Canada can't block dodgy drug importsRead the original story w/Photo

    Sep 19, 2014 | The Toronto Star

    Canadian drug regulator Health Canada failed to stop pharmaceutical giant Apotex from importing suspect drug ingredients from one of its troubled manufacturing plants in India. Instead, the potentially unsafe products were allowed into the country to be used in the making of generic blood pressure medications, antihistamines and other drugs for Canadian consumption.

    Comment?